


Headquarters
611 Gateway Boulevard
Suite 120
South San Francisco, CA 94080
Vijai is the founder and CEO of Secure Transfusion Services. He spent nearly two decades as a life sciences institutional investor in both private equity and hedge funds, including senior positions at Arcline Investment Management and Origin Capital Management. Previously in his career, he managed corporate finance and investor relations at Onyx Pharmaceuticals, an early gene therapy pioneer. Vijai graduated with a BA in Economics and Molecular Biology, in addition to a Masters in Biotechnology from the University of Pennsylvania.
SECURE TRANSFUSION SERVICES
611 Gateway Boulevard, Suite 120
South San Francisco, CA 94080
www.securetransfusion.com
April 30, 2020
Dear Secure Transfusion Services, Inc. (“STS”) Stakeholder,
During these unprecedented times, I hope you and your loved ones are faring well and are healthy. We remain grateful to the healthcare professionals and service workers who risk their safety to treat patients. Despite the broader disruptions to our economy and society in general, STS continues to advance its mission to enhance the safety and availability of key transfusable blood components, bringing a sustainable, ethical, and secure means of ending platelet availability challenges.
We have recently been asked about the impact the COVID-19 pandemic is having on our business and expansion strategy. In response, I highlight the following:
It is our privilege to serve the communities in which we operate. Above all, a passion for the safety of our donors and the commitment to improved patient outcomes constitute the core of our mission.
With best regards,
Vijai Mohan
Founder and CEO